| 1 |
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gϋnter von Minckwitz et al. · The Lancet Oncology
|
30 Apr 2014 |
1,048 |
| 2 |
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
S. Loibl et al. · Annals of Oncology
Open access |
7 May 2019 |
714 |
| 3 |
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Miguel Martín et al. · The Lancet Oncology
626 authors |
13 Nov 2017 |
594 |
| 4 |
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Arlene Chan et al. · The Lancet Oncology
|
12 Feb 2016 |
569 |
| 5 |
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
Michael Untch, Sibylle Loibl, Joachim Bischoff et al. · The Lancet Oncology
|
16 Jan 2012 |
459 |
| 6 |
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto
Sibylle Loibl et al. · Annals of Oncology
Open access |
15 Oct 2018 |
308 |
| 7 |
PIK3CA Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti–Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer
Sibylle Loibl et al. · Journal of Clinical Oncology
Open access |
9 Sep 2014 |
261 |
| 8 |
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer
Barbara Ingold Heppner et al. · Clinical Cancer Research
|
17 May 2016 |
204 |
| 9 |
Neoadjuvant bevacizumab and anthracycline–taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
Bernhard Gerber, Sibylle Loibl, Holger Eidtmann et al. · Annals of Oncology
Open access |
18 Oct 2013 |
156 |
| 10 |
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
Wolfgang EIERMANN, Mahdi Rezai, Sherko Kümmel et al. · Annals of Oncology
Open access |
8 Nov 2012 |
147 |
| 11 |
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
Gϋnter von Minckwitz et al. · Annals of Oncology
Open access149 authors |
16 Sep 2014 |
140 |
| 12 |
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial
Andreas Schneeweiß et al. · European Journal of Cancer
|
4 Dec 2018 |
106 |
| 13 |
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)
Sibylle Loibl, Lorena de la Peña, Valentina Nekljudova et al. · European Journal of Cancer
Open access |
18 Sep 2017 |
104 |
| 14 |
Impact of Multifocal or Multicentric Disease on Surgery and Locoregional, Distant and Overall Survival of 6,134 Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Beyhan Ataseven, Bianca Lederer, Jens‐Uwe Blohmer et al. · Annals of Surgical Oncology
|
8 Oct 2014 |
102 |
| 15 |
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials
Sonia Lorena Villegas et al. · European Journal of Cancer
|
18 Mar 2021 |
90 |
| 16 |
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
Sunil R. Lakhani, Werner Audretsch, Anne-Marie Cleton-Jensen et al. · European Journal of Cancer
|
30 Jul 2006 |
87 |
| 17 |
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
Gϋnter von Minckwitz, Mahdi Rezai, Peter Andreas Fasching et al. · Annals of Oncology
Open access |
23 Nov 2013 |
80 |
| 18 |
Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab – Results of the randomised GeparQuinto study (GBG 44)
Jens Huober et al. · European Journal of Cancer
|
27 Mar 2013 |
79 |
| 19 |
Impact of Age, Obesity and Smoking on Patient Satisfaction with Breast Implant Surgery – A Unicentric Analysis of 318 Implant Reconstructions after Mastectomy
Peter Kern, F. Zarth, Rainer Kimmig et al. · Geburtshilfe und Frauenheilkunde
Open access |
3 Jul 2015 |
73 |
| 20 |
Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003–2007) from Germany as a proof of concept
Sara Yvonne Brucker, Claudia Schumacher, Christoph Sohn et al. · BMC Cancer
Open access |
Dec 2008 |
64 |
| 21 |
Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting
Jens‐Uwe Blohmer, Mahdi Rezai, Sherko Kümmel et al. · Journal of Medical Economics
Open access |
11 Sep 2012 |
55 |
| 22 |
Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study
Naiba Nabieva et al. · European Journal of Cancer
|
18 Apr 2018 |
50 |
| 23 |
Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort
Kerstin Rhiem, Hans‐Joachim Bücker‐Nott, Martin Hellmich et al. · The Breast Journal
Open access |
5 Apr 2019 |
49 |
| 24 |
Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients
Naiba Nabieva et al. · Annals of Oncology
Open access |
5 Oct 2017 |
44 |
| 25 |
Imaging in patients with breast implants—results of the First International Breast (Implant) Conference 2009
F. Stöblen, Mahdi Rezai, Sherko Kümmel · Insights into Imaging
Open access |
May 2010 |
40 |
| 26 |
Systematization of Oncoplastic Surgery: Selection of Surgical Techniques and Patient-Reported Outcome in a Cohort of 1,035 Patients
Mahdi Rezai, Sarah Knispel, Stephanie Kellersmann et al. · Annals of Surgical Oncology
Open access |
11 Feb 2015 |
40 |
| 27 |
Clinical relevance and concordance of HER2 status in local and central testing—an analysis of 1581 HER2-positive breast carcinomas over 12 years
Berit Maria Pfitzner et al. · Modern Pathology
Open access |
22 Dec 2017 |
38 |
| 28 |
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III G epar Q uinto study
Alexander Hein et al. · International Journal of Cancer
Open access |
23 Jun 2015 |
33 |
| 29 |
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
Gϋnter von Minckwitz et al. · European Journal of Cancer
|
18 Jun 2016 |
32 |
| 30 |
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
André Hennigs, Melitta Beatrice Köpke, Manuel Feißt et al. · Breast Cancer Research and Treatment
|
12 Oct 2018 |
30 |
| 31 |
Breast conservative surgery and local recurrence
Mahdi Rezai, Stefan Kraemer, Rainer Kimmig et al. · The Breast
Open access |
2 Oct 2015 |
30 |
| 32 |
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study
Carolin C. Hack et al. · Integrative Cancer Therapies
Open access |
14 Sep 2016 |
29 |
| 33 |
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial
Stephen Chia et al. · Breast Cancer Research
Open access |
11 Mar 2019 |
28 |
| 34 |
Surgical Outcome after Neoadjuvant Chemotherapy and Bevacizumab: Results from the GeparQuinto Study (GBG 44)
Bernd Gerber, Gϋnter von Minckwitz, Holger Eidtmann et al. · Annals of Surgical Oncology
|
16 Apr 2014 |
28 |
| 35 |
Lessons from the neoadjuvant setting on how best to choose adjuvant therapies
Gϋnter von Minckwitz, Sibylle Loibl, Andrea Maisch et al. · The Breast
Open access |
Oct 2011 |
27 |
| 36 |
Breast-Conserving Treatment of Breast Cancer – Oncological and Reconstructive Aspects
Stefan Krämer, Maren Darsow, Sherko Kümmel et al. · Gyn�kologisch-geburtshilfliche Rundschau
|
2008 |
26 |
| 37 |
Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother
Christian Willaschek, Eike Wolter, Reiner Buchhorn · European Journal of Clinical Pharmacology
|
15 Dec 2008 |
25 |
| 38 |
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial
Bernd Tombach et al. · European Radiology
Open access |
7 Jul 2008 |
25 |
| 39 |
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial
Sherko Küemmel et al. · Journal of Clinical Oncology
|
May 2019 |
24 |
| 40 |
Autologous and Alloplastic Breast Reconstruction – Overview of Techniques, Indications and Results
Mahdi Rezai, Maren Darsow, Sherko Kümmel et al. · Gyn�kologisch-geburtshilfliche Rundschau
|
2008 |
23 |
| 41 |
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto
Elena Laakmann et al. · Breast Cancer Research
Open access |
10 May 2019 |
22 |
| 42 |
Long-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto)
Michael Untch, Andreas Schneeweiß, Christoph Salat et al. · Annals of Oncology
Open access |
Sep 2017 |
21 |
| 43 |
Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial
Oleg Gluz et al. · Annals of Oncology
Open access |
14 Apr 2023 |
20 |
| 44 |
Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study
André Hennigs, Fabian Riedel, Manuel Feißt et al. · Annals of Surgical Oncology
|
2 May 2019 |
20 |
| 45 |
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial
Melanie Janning et al. · International Journal of Cancer
Open access |
29 Jan 2019 |
20 |
| 46 |
Breast Cancer Mastectomy Trends Between 2006 and 2010: Association with Magnetic Resonance Imaging, Immediate Breast Reconstruction, and Hospital Volume
Joerg Heil, Geraldine Rauch, Ákos Szabó et al. · Annals of Surgical Oncology
|
9 Jul 2013 |
20 |
| 47 |
Evaluation of Two Different Analytical Methods for Circulating Tumor Cell Detection in Peripheral Blood of Patients with Primary Breast Cancer
Bernadette AS Jaeger, Julia Kathrin Jueckstock, Ulrich Andergassen et al. · BioMed Research International
Open access |
2014 |
19 |
| 48 |
Der Antrieb als psychische Grundfunktion
Wolfgang Klages · European Archives of Psychiatry and Clinical Neuroscience
|
1964 |
18 |
| 49 |
Klinisch-psychopathologische Beobachtungen bei chronischem Mi�brauch von Ephedrin und verwandten Substanzen
Friedrich Panse, Wolfgang Klages · European Archives of Psychiatry and Clinical Neuroscience
|
1964 |
18 |
| 50 |
Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival
Peter M. Kern, Anne Kalisch, Gϋnter von Minckwitz et al. · Journal of Chemotherapy
|
4 Aug 2015 |
18 |